Back to the main list of congress faculty

BIOGRAPHY   Howard Feldman, MD Professor and Head Division of Neurology University of British Columbia, Faculty of Medicine Vancouver, British Columbia, Canada Howard Feldman, MD, CM, FRCP (C), is Professor and Head of the Division of Neurology at the University of British Columbia (UBC) and Vancouver Hospital, both in Vancouver, Canada. He holds an appointment as well as Adjunct Professor at the McGill Centre for Studies in Aging in Montreal. Dr Feldman is the Director of the Clinic for Alzheimer Disease and Related Disorders at UBC. In his clinical research activities, Dr Feldman has been active in both epidemiological and clinical diagnostic/therapeutic studies in Alzheimer’s disease. He has been principal investigator for a number of large international studies with cholinesterase inhibitors and other experimental approaches in Alzheimer’s disease. His research unit has also been involved in studies of genotype and phenotype in frontotemporal degenerations, as well as in cohort studies of individuals with mild cognitive impairment with aging. He has held numerous peer-reviewed grants for this research from the Canadian Institutes of Health Research, the Alzheimer Society of Canada, and the National Institutes of Health. Dr Feldman’s work has been published over 175 times in peer-reviewed professional journals and texts. He has lectured globally on Alzheimer-related issues including the presentation and progression of Alzheimer’s disease as well as emerging treatment strategies. One of his papers in Lancet Neurology was the most downloaded for the journal on Science Direct in 2003, while other seminal publications have focused on clinical trials methodologies, and treatment interventions. He is a member of numerous professional societies, including the American Academy of Neurology, the Canadian Congress of Neurological Sciences and the Canadian Consortium of Clinical Cognitive Research Centers (CSR) of which he is a former president. He has been active as a member of the Steering Committee of the International Working Group on Harmonization of Dementia Drug Guidelines and is a member of the Medical and Scientific Advisory Board of Alzheimer’s Disease International and has been advisor to the European Institute of Women’s Health. He serves on the editorial boards of numerous journals and acts as peer reviewer of Alzheimer’s disease grants and articles for numerous granting agencies including the Canadian Institutes of Health Research, the Alzheimers’ Society and the Institute for the Study of Aging.